BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8434875)

  • 1. Multiple sclerosis: remyelination of nascent lesions.
    Prineas JW; Barnard RO; Kwon EE; Sharer LR; Cho ES
    Ann Neurol; 1993 Feb; 33(2):137-51. PubMed ID: 8434875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
    Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remyelination is extensive in a subset of multiple sclerosis patients.
    Patrikios P; Stadelmann C; Kutzelnigg A; Rauschka H; Schmidbauer M; Laursen H; Sorensen PS; Brück W; Lucchinetti C; Lassmann H
    Brain; 2006 Dec; 129(Pt 12):3165-72. PubMed ID: 16921173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions.
    Itoyama Y; Webster HD; Richardson EP; Trapp BD
    Ann Neurol; 1983 Sep; 14(3):339-46. PubMed ID: 6195956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
    Chang A; Tourtellotte WW; Rudick R; Trapp BD
    N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
    Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remyelination capacity of the MS brain decreases with disease chronicity.
    Goldschmidt T; Antel J; König FB; Brück W; Kuhlmann T
    Neurology; 2009 Jun; 72(22):1914-21. PubMed ID: 19487649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remyelination in multiple sclerosis.
    Lassmann H; Brück W; Lucchinetti C; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):133-6. PubMed ID: 9291167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.
    Nakahara J; Aiso S; Suzuki N
    Expert Opin Ther Targets; 2009 Dec; 13(12):1375-86. PubMed ID: 19839715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
    Raine CS; Scheinberg L; Waltz JM
    Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis. Pathology of recurrent lesions.
    Prineas JW; Barnard RO; Revesz T; Kwon EE; Sharer L; Cho ES
    Brain; 1993 Jun; 116 ( Pt 3)():681-93. PubMed ID: 8513397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remyelination in multiple sclerosis.
    Prineas JW; Connell F
    Ann Neurol; 1979 Jan; 5(1):22-31. PubMed ID: 426466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Cho ES; Sharer LR
    Lab Invest; 1990 Nov; 63(5):624-36. PubMed ID: 1700195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: remyelination in acute lesions.
    Raine CS; Wu E
    J Neuropathol Exp Neurol; 1993 May; 52(3):199-204. PubMed ID: 7684075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.